These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36576812)

  • 1. Performance of Cardiovascular Risk Prediction Models Among People Living With HIV: A Systematic Review and Meta-analysis.
    Soares C; Kwok M; Boucher KA; Haji M; Echouffo-Tcheugui JB; Longenecker CT; Bloomfield GS; Ross D; Jutkowtiz E; Sullivan JL; Rudolph JL; Wu WC; Erqou S
    JAMA Cardiol; 2023 Feb; 8(2):139-149. PubMed ID: 36576812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive Performance of Cardiovascular Disease Risk Prediction Algorithms in People Living With HIV.
    van Zoest RA; Law M; Sabin CA; Vaartjes I; van der Valk M; Arends JE; Reiss P; Wit FW
    J Acquir Immune Defic Syndr; 2019 Aug; 81(5):562-571. PubMed ID: 31045648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular Disease Risk Prediction in the HIV Outpatient Study.
    Thompson-Paul AM; Lichtenstein KA; Armon C; Palella FJ; Skarbinski J; Chmiel JS; Hart R; Wei SC; Loustalot F; Brooks JT; Buchacz K
    Clin Infect Dis; 2016 Dec; 63(11):1508-1516. PubMed ID: 27613562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Risk Estimation Is Suboptimal in People With HIV.
    Triant VA; Lyass A; Hurley LB; Borowsky LH; Ehrbar RQ; He W; Cheng D; Lo J; Klein DB; Meigs JB; Grinspoon SK; Plutzky J; Silverberg MJ; LaValley M; Massaro JM; D'Agostino RB
    J Am Heart Assoc; 2024 May; 13(10):e029228. PubMed ID: 38761071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction models for cardiovascular disease risk among people living with HIV: A systematic review and meta-analysis.
    Yu J; Liu X; Zhu Z; Yang Z; He J; Zhang L; Lu H
    Front Cardiovasc Med; 2023; 10():1138234. PubMed ID: 37034346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection.
    Triant VA; Perez J; Regan S; Massaro JM; Meigs JB; Grinspoon SK; D'Agostino RB
    Circulation; 2018 May; 137(21):2203-2214. PubMed ID: 29444987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk prediction in HIV-infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) risk prediction models.
    Krikke M; Hoogeveen RC; Hoepelman AI; Visseren FL; Arends JE
    HIV Med; 2016 Apr; 17(4):289-97. PubMed ID: 26268806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of four international cardiovascular disease prediction models and the prevalence of eligibility for lipid lowering therapy in HIV infected patients on antiretroviral therapy.
    Begovac J; Dragović G; Višković K; Kušić J; Perović Mihanović M; Lukas D; Jevtović Đ
    Croat Med J; 2015 Feb; 56(1):14-23. PubMed ID: 25727038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease risk among Chinese antiretroviral-naïve adults with advanced HIV disease.
    Guo F; Hsieh E; Lv W; Han Y; Xie J; Li Y; Song X; Li T
    BMC Infect Dis; 2017 Apr; 17(1):287. PubMed ID: 28427339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution and Performance of Cardiovascular Risk Scores in a Mixed Population of HIV-Infected and Community-Based HIV-Uninfected Individuals in Uganda.
    Muiru AN; Bibangambah P; Hemphill L; Sentongo R; Kim JH; Triant VA; Bangsberg DR; Tsai AC; Martin JN; Haberer JE; Boum Y; Plutzky J; Hunt PW; Okello S; Siedner MJ
    J Acquir Immune Defic Syndr; 2018 Aug; 78(4):458-464. PubMed ID: 29652762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the Framingham risk models and pooled cohort equations for predicting 10-year risk of cardiovascular disease: a systematic review and meta-analysis.
    Damen JA; Pajouheshnia R; Heus P; Moons KGM; Reitsma JB; Scholten RJPM; Hooft L; Debray TPA
    BMC Med; 2019 Jun; 17(1):109. PubMed ID: 31189462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing Cardiovascular Risk in People Living with HIV: Current Tools and Limitations.
    Achhra AC; Lyass A; Borowsky L; Bogorodskaya M; Plutzky J; Massaro JM; D'Agostino RB; Triant VA
    Curr HIV/AIDS Rep; 2021 Aug; 18(4):271-279. PubMed ID: 34247329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External validation and clinical usefulness of three commonly used cardiovascular risk prediction scores in an Emirati population: a retrospective longitudinal cohort study.
    Al-Shamsi S; Govender RD; King J
    BMJ Open; 2020 Oct; 10(10):e040680. PubMed ID: 33115904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of future cardiovascular events by Framingham, SCORE and asCVD risk scores is less accurate in HIV-positive individuals from the HIV-HEART Study compared with the general population.
    Schulz CA; Mavarani L; Reinsch N; Albayrak-Rena S; Potthoff A; Brockmeyer N; Hower M; Erbel R; Jöckel KH; Schmidt B; Esser S;
    HIV Med; 2021 Sep; 22(8):732-741. PubMed ID: 34028959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk assessment in people living with HIV compared to the general population.
    Delabays B; Cavassini M; Damas J; Beuret H; Calmy A; Hasse B; Bucher HC; Frischknecht M; Müller O; Méan M; Vollenweider P; Marques-Vidal P; Vaucher J
    Eur J Prev Cardiol; 2022 Mar; 29(4):689-699. PubMed ID: 34893801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive performance of established cardiovascular risk scores in the prediabetic population: external validation using the UK Biobank data set.
    Li M; Lin Y; Zhong X; Huang R; Zhang S; Liu M; Liu S; Ye X; Xu X; Huang Y; Xiong Z; Guo Y; Liao X; Zhuang X
    Eur J Prev Cardiol; 2023 Oct; 30(14):1427-1438. PubMed ID: 37036042
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.